Global X Telemedicine & Digital Health ETF (EDOC)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Global X Telemedicine & Digital Health ETF (EDOC) with AI Score 44/100 (Weak). Global X Telemedicine & Digital Health ETF (EDOC) is a non-diversified fund seeking to track the Solactive Telemedicine & Digital Health Index. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 18, 2026Global X Telemedicine & Digital Health ETF (EDOC) Financial Services Profile
Global X Telemedicine & Digital Health ETF (EDOC) offers targeted exposure to companies benefiting from the growth of telemedicine and digital health. As a non-diversified fund utilizing a passive indexing approach, EDOC tracks the Solactive Telemedicine & Digital Health Index, providing investors access to this evolving sector.
Investment Thesis
The Global X Telemedicine & Digital Health ETF (EDOC) presents a targeted investment opportunity in the burgeoning telemedicine and digital health sector. As of 2026-03-18, the fund has a market capitalization of $0.04 billion and a beta of 1.29. The absence of a dividend yield reflects the growth-oriented nature of the underlying companies. Key value drivers include the increasing adoption of telehealth services, advancements in digital health technologies, and favorable regulatory trends. Growth catalysts include the expansion of remote patient monitoring, the rise of digital therapeutics, and the integration of AI in healthcare. Potential risks include regulatory uncertainties, competition from established healthcare providers, and technological obsolescence. The fund's performance is closely tied to the success of the companies within its underlying index, making it essential to monitor industry trends and competitive dynamics.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $0.04 billion as of 2026-03-18 indicates a relatively small fund focused on a niche sector.
- Beta of 1.29 suggests higher volatility compared to the broader market, reflecting the growth-oriented nature of the telemedicine and digital health industry.
- Absence of dividend yield aligns with the fund's focus on capital appreciation rather than income generation.
- Passive indexing approach aims to replicate the performance of the Solactive Telemedicine & Digital Health Index.
- Non-diversified structure concentrates investments in a smaller number of issuers, potentially increasing risk and reward.
Competitors & Peers
Strengths
- Targeted exposure to the high-growth telemedicine and digital health sector.
- Passive indexing approach provides cost-effective investment solution.
- Potential for high returns due to the rapid growth of the underlying industry.
- Transparent and liquid investment vehicle.
Weaknesses
- Non-diversified structure increases risk compared to broader market ETFs.
- Performance is highly dependent on the success of the telemedicine and digital health sector.
- Vulnerable to regulatory changes and technological obsolescence.
- Absence of dividend yield may not appeal to income-seeking investors.
Catalysts
- Ongoing: Increasing adoption of telehealth services due to convenience and accessibility.
- Ongoing: Technological advancements in remote patient monitoring and digital therapeutics.
- Ongoing: Favorable regulatory environment and government support for telemedicine.
- Upcoming: Potential expansion of telehealth reimbursement policies in various states and countries.
- Upcoming: New product launches and innovations in the digital health space.
Risks
- Potential: Regulatory uncertainties and changes in reimbursement policies.
- Potential: Competition from established healthcare providers and technology companies.
- Potential: Technological obsolescence and rapid innovation in the healthcare sector.
- Ongoing: Market volatility and economic downturns.
- Ongoing: Cybersecurity risks and data privacy concerns in the digital health space.
Growth Opportunities
- Expansion of Telehealth Platforms: The global telehealth market is projected to reach $55.6 billion by 2027, growing at a CAGR of 25.9% from 2020. EDOC is positioned to benefit from the increasing adoption of telehealth platforms, which enable remote consultations, virtual care, and remote patient monitoring. As healthcare providers and patients embrace telehealth, the demand for these platforms is expected to continue to rise, driving growth for companies within EDOC's portfolio.
- Rise of Digital Therapeutics: The digital therapeutics market is expected to reach $9.65 billion by 2030, growing at a CAGR of 29.7% from 2021. Digital therapeutics offer evidence-based interventions to prevent, manage, or treat medical conditions using software and digital technologies. EDOC's exposure to companies developing and commercializing digital therapeutics positions it to capitalize on this rapidly expanding market.
- Integration of AI in Healthcare: The artificial intelligence (AI) in healthcare market is projected to reach $95.65 billion by 2030, growing at a CAGR of 37.4% from 2022. AI is transforming healthcare by enabling more accurate diagnoses, personalized treatment plans, and efficient healthcare operations. EDOC's portfolio includes companies that are leveraging AI to develop innovative healthcare solutions, positioning it to benefit from this transformative trend.
- Remote Patient Monitoring: The remote patient monitoring market is expected to reach $178.1 billion by 2028, growing at a CAGR of 17.1% from 2021. Remote patient monitoring devices and platforms enable healthcare providers to track patients' vital signs and health data remotely, improving patient outcomes and reducing healthcare costs. EDOC's exposure to companies involved in remote patient monitoring positions it to capitalize on this growing market.
- Favorable Regulatory Environment: Government initiatives and regulatory changes are supporting the growth of telemedicine and digital health. For example, the expansion of telehealth reimbursement policies and the relaxation of regulations related to remote prescribing are driving adoption of these technologies. EDOC is positioned to benefit from these favorable regulatory trends, which are creating a more conducive environment for the growth of telemedicine and digital health companies.
Opportunities
- Increasing adoption of telehealth and digital health technologies.
- Expansion of remote patient monitoring and digital therapeutics.
- Integration of AI and machine learning in healthcare.
- Favorable regulatory environment and government support for telemedicine.
Threats
- Competition from established healthcare providers and technology companies.
- Regulatory uncertainties and changes in reimbursement policies.
- Technological obsolescence and rapid innovation in the healthcare sector.
- Economic downturns and market volatility.
Competitive Advantages
- First-mover advantage in offering a dedicated ETF focused on telemedicine and digital health.
- Passive indexing approach provides cost-effective exposure to the sector.
- Established track record and brand recognition within the ETF market.
About EDOC
The Global X Telemedicine & Digital Health ETF (EDOC) was created to provide investors with focused exposure to the rapidly evolving telemedicine and digital health industry. EDOC operates by tracking the Solactive Telemedicine & Digital Health Index, which is designed to identify and include companies that are expected to benefit from advancements in telemedicine and digital health technologies. The fund employs a passive or indexing investment strategy, aiming to replicate the performance of its underlying index. This approach involves holding a portfolio of stocks that mirrors the index's composition, with adjustments made periodically to reflect changes in the index. EDOC is a non-diversified fund, meaning it can invest a significant portion of its assets in a smaller number of issuers compared to a diversified fund. While this can potentially lead to higher returns if the selected companies perform well, it also increases the fund's risk profile. The fund's investments are primarily in exchange-listed companies that are considered to be at the forefront of telemedicine and digital health innovation. These companies may be involved in various aspects of the industry, including telehealth platforms, remote patient monitoring, digital therapeutics, and healthcare analytics. By focusing on a specific sector, EDOC offers investors a targeted way to participate in the growth of telemedicine and digital health. However, it's important to note that the fund's performance is closely tied to the performance of the companies within its underlying index and the overall health of the telemedicine and digital health industry.
What They Do
- Tracks the Solactive Telemedicine & Digital Health Index.
- Provides exposure to companies benefiting from advancements in telemedicine and digital health.
- Employs a passive indexing approach to replicate the performance of the underlying index.
- Invests in exchange-listed companies involved in telehealth platforms, remote patient monitoring, and digital therapeutics.
- Offers investors a targeted way to participate in the growth of the telemedicine and digital health sector.
- Rebalances its portfolio periodically to reflect changes in the composition of the underlying index.
Business Model
- Tracks the Solactive Telemedicine & Digital Health Index.
- Generates revenue through management fees charged to investors.
- Utilizes a passive indexing approach to minimize costs and track the performance of the underlying index.
Industry Context
The Global X Telemedicine & Digital Health ETF (EDOC) operates within the asset management industry, specifically focusing on the telemedicine and digital health sector. This sector is experiencing rapid growth, driven by factors such as increasing demand for remote healthcare services, technological advancements, and favorable regulatory changes. The competitive landscape includes other ETFs and investment funds that offer exposure to the healthcare or technology sectors. EDOC differentiates itself by providing targeted exposure to companies specifically involved in telemedicine and digital health. Competitors include ABLG, ADRD, CLSA, IUSS and MDCP. This targeted approach allows investors to capitalize on the specific growth drivers within this niche market.
Key Customers
- Individual investors seeking exposure to the telemedicine and digital health sector.
- Institutional investors looking for targeted investments in innovative healthcare technologies.
- Financial advisors seeking to diversify client portfolios with thematic ETFs.
Financials
Chart & Info
Global X Telemedicine & Digital Health ETF (EDOC) stock price: Price data unavailable
Latest News
-
Agilent Bets On Pathology Innovation With Biocare Acquisition
benzinga · Mar 9, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for EDOC.
Price Targets
Wall Street price target analysis for EDOC.
MoonshotScore
What does this score mean?
The MoonshotScore rates EDOC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
What Investors Ask About Global X Telemedicine & Digital Health ETF (EDOC)
What does Global X Telemedicine & Digital Health ETF do?
Global X Telemedicine & Digital Health ETF (EDOC) is designed to provide investors with targeted exposure to companies that are positioned to benefit from advancements in telemedicine and digital health technologies. The fund tracks the Solactive Telemedicine & Digital Health Index, which includes exchange-listed companies involved in telehealth platforms, remote patient monitoring, digital therapeutics, and healthcare analytics. By investing in EDOC, investors can gain access to a portfolio of companies that are at the forefront of innovation in the healthcare sector, without having to individually select and manage these investments.
What do analysts say about EDOC stock?
AI analysis is pending for EDOC as of 2026-03-18. Generally, analysts covering ETFs focus on factors such as the fund's expense ratio, tracking error, and the performance of its underlying index. For EDOC, analysts would likely consider the growth prospects of the telemedicine and digital health sector, as well as the fund's ability to accurately track the Solactive Telemedicine & Digital Health Index. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions.
What are the main risks for EDOC?
The main risks for Global X Telemedicine & Digital Health ETF (EDOC) include regulatory uncertainties, competition from established healthcare providers and technology companies, and technological obsolescence. Regulatory changes, such as changes in telehealth reimbursement policies, could negatively impact the growth of the telemedicine and digital health sector. Additionally, competition from larger, more established companies could limit the growth potential of the companies within EDOC's portfolio. Finally, rapid technological advancements could render existing technologies obsolete, requiring companies to constantly innovate to stay competitive.
What are the key factors to evaluate for EDOC?
Global X Telemedicine & Digital Health ETF (EDOC) currently holds an AI score of 44/100, indicating low score. Key strength: Targeted exposure to the high-growth telemedicine and digital health sector.. Primary risk to monitor: Potential: Regulatory uncertainties and changes in reimbursement policies.. This is not financial advice.
How frequently does EDOC data refresh on this page?
EDOC prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EDOC's recent stock price performance?
Recent price movement in Global X Telemedicine & Digital Health ETF (EDOC) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Targeted exposure to the high-growth telemedicine and digital health sector.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EDOC overvalued or undervalued right now?
Determining whether Global X Telemedicine & Digital Health ETF (EDOC) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EDOC?
Before investing in Global X Telemedicine & Digital Health ETF (EDOC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The information provided is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial goals.
- Past performance is not indicative of future results.